Table: Kaken Pharmaceutical -2024/25 group results

KAKEN PHARMACEUTICAL

12/05/2025 07:32

May 12 (Reuters)- 
          Kaken Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2025    Mar 31, 2024   Mar 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           94.04           72.04          88.00                 
               (+30.5 pct)     (-1.3 pct)     (-6.4 pct)               
  Operating       21.03            9.51           5.20                 
              (+121.1 pct)     (+18.9 pct)    (-75.3 pct)              
  Recurring       21.28            9.95           6.00                 
              (+113.8 pct)     (+14.0 pct)    (-71.8 pct)              
  Net
  Net             13.95            8.03           3.40                 
               (+73.8 pct)     (+47.5 pct)    (-75.6 pct)              
  EPS          365.42 yen      212.67 yen      88.53 yen               
  Ann Div      190.00 yen      150.00 yen     190.00 yen               
  -Q2 Div      115.00 yen       75.00 yen      95.00 yen               
  -Q4 Div       75.00 yen       75.00 yen      95.00 yen               
  
  NOTE - Kaken Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4521.T